February 25, 2025 06:45 AM EST
Pharma
Marketing

Eli Lil­ly ex­pands Zep­bound sin­gle-dose vial op­tions at low­er price

Nicole DeFeudis

Editor

Eli Lil­ly will start sell­ing ad­di­tion­al sin­gle-dose vials of its weight loss drug Zep­bound at a low­er price for cer­tain pa­tients.

The com­pa­ny

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA’s pol­i­cy, com­mu­ni­ca­tions staff like­ly to be among agency’s 3,500 staff cuts

With tar­iffs on the way, gener­ic drug­mak­ing woes could hin­der Trump’s reshoring plan 

Kennedy an­nounces 10,000 job cuts at HHS, with ma­jor re­duc­tions ex­pect­ed at FDA, NIH and CDC

Ex­clu­sive: Met­sera CEO on what it takes to build an obe­si­ty biotech in 2025

Mer­ck de­tails in­jectable Keytru­da da­ta as it awaits au­tumn FDA de­ci­sion

Three ma­jor ques­tions on phar­ma tar­iffs Trump claims are on the way

A service from the Financial Times